Cargando…

Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease

Skin biomechanical parameters (dynamic stiffness, frequency, relaxation time, creep, and decrement) measured using a myotonometer (MyotonPRO) could inform the management of sclerotic disease. To determine which biomechanical parameter(s) can accurately differentiate patients with sclerotic chronic g...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Laura X., Chen, Fuyao, Cronin, Austin, Chen, Heidi, Vain, Arved, Jagasia, Madan, Tkaczyk, Eric R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594905/
https://www.ncbi.nlm.nih.gov/pubmed/34790906
http://dx.doi.org/10.1016/j.xjidi.2021.100037
_version_ 1784600082391236608
author Baker, Laura X.
Chen, Fuyao
Cronin, Austin
Chen, Heidi
Vain, Arved
Jagasia, Madan
Tkaczyk, Eric R.
author_facet Baker, Laura X.
Chen, Fuyao
Cronin, Austin
Chen, Heidi
Vain, Arved
Jagasia, Madan
Tkaczyk, Eric R.
author_sort Baker, Laura X.
collection PubMed
description Skin biomechanical parameters (dynamic stiffness, frequency, relaxation time, creep, and decrement) measured using a myotonometer (MyotonPRO) could inform the management of sclerotic disease. To determine which biomechanical parameter(s) can accurately differentiate patients with sclerotic chronic graft-versus-host disease from post–hematopoietic cell transplant controls, 15 patients with sclerotic chronic graft-versus-host disease and 11 post–hematopoietic cell transplant controls were measured with the myotonometer on 18 anatomic sites. Logistic regression and two machine learning algorithms (least absolute shrinkage and selection operator regression and random forest) were developed to classify subjects. In univariable analysis, frequency had the highest overfit-corrected area under the curve (0.91). Backward stepwise selection and random forest machine learning identified frequency and relaxation time as the optimal parameters for differentiating patients with sclerotic chronic graft-versus-host disease from post–hematopoietic cell transplant controls. Least absolute shrinkage and selection operator regression selected the combination of frequency and relaxation time (overfit-corrected area under the curve = 0.87). Discriminatory ability was maintained when only the sites accessible while the patient is supine (12 sites) were used. We report the distribution of values for these highly discriminative biomechanical parameters, which could inform the assessment of disease severity in future quantitative biomechanical studies of sclerotic chronic graft-versus-host disease.
format Online
Article
Text
id pubmed-8594905
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85949052021-11-16 Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease Baker, Laura X. Chen, Fuyao Cronin, Austin Chen, Heidi Vain, Arved Jagasia, Madan Tkaczyk, Eric R. JID Innov Original Article Skin biomechanical parameters (dynamic stiffness, frequency, relaxation time, creep, and decrement) measured using a myotonometer (MyotonPRO) could inform the management of sclerotic disease. To determine which biomechanical parameter(s) can accurately differentiate patients with sclerotic chronic graft-versus-host disease from post–hematopoietic cell transplant controls, 15 patients with sclerotic chronic graft-versus-host disease and 11 post–hematopoietic cell transplant controls were measured with the myotonometer on 18 anatomic sites. Logistic regression and two machine learning algorithms (least absolute shrinkage and selection operator regression and random forest) were developed to classify subjects. In univariable analysis, frequency had the highest overfit-corrected area under the curve (0.91). Backward stepwise selection and random forest machine learning identified frequency and relaxation time as the optimal parameters for differentiating patients with sclerotic chronic graft-versus-host disease from post–hematopoietic cell transplant controls. Least absolute shrinkage and selection operator regression selected the combination of frequency and relaxation time (overfit-corrected area under the curve = 0.87). Discriminatory ability was maintained when only the sites accessible while the patient is supine (12 sites) were used. We report the distribution of values for these highly discriminative biomechanical parameters, which could inform the assessment of disease severity in future quantitative biomechanical studies of sclerotic chronic graft-versus-host disease. Elsevier 2021-06-24 /pmc/articles/PMC8594905/ /pubmed/34790906 http://dx.doi.org/10.1016/j.xjidi.2021.100037 Text en © 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Baker, Laura X.
Chen, Fuyao
Cronin, Austin
Chen, Heidi
Vain, Arved
Jagasia, Madan
Tkaczyk, Eric R.
Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease
title Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease
title_full Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease
title_fullStr Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease
title_full_unstemmed Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease
title_short Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease
title_sort optimal biomechanical parameters for measuring sclerotic chronic graft-versus-host disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594905/
https://www.ncbi.nlm.nih.gov/pubmed/34790906
http://dx.doi.org/10.1016/j.xjidi.2021.100037
work_keys_str_mv AT bakerlaurax optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease
AT chenfuyao optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease
AT croninaustin optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease
AT chenheidi optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease
AT vainarved optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease
AT jagasiamadan optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease
AT tkaczykericr optimalbiomechanicalparametersformeasuringscleroticchronicgraftversushostdisease